Germany Influenza Vaccine Market Size, Share, and COVID-19 Impact Analysis, By Vaccine Type (Inactivated and Live Attenuated), By Indication (Quadrivalent and Trivalent), By Distribution Channel (Hospitals & Pharmacies, Government & Institutional Supply, and Other), and Germany Influenza Vaccine Market Insights, Industry Trend, Forecasts to 2033

Germany Influenza Vaccine Market Insights Forecasts to 2033

• The Germany Influenza Vaccine Market Size Was Valued at USD 240.3 Million in 2023.
• The Germany Influenza Vaccine Market Size is Growing at a CAGR of 5.98% from 2023 to 2033
• The Germany Influenza Vaccine Market Size is Expected to reach USD 429.5 Million By 2033

The Germany Influenza Vaccine Market Size is Anticipated to exceed USD 429.5 Million by 2033, Growing at a CAGR of 5.98% from 2023 to 2033. The rising public health needs, vaccine efficacy, and technological advancement in vaccine development are driving the influenza vaccine market in the Germany.     

Market Overview

The influenza vaccine market comprises pharmaceutical companies involved in researching, developing, producing, and marketing vaccines to protect against influenza viruses. Influenza vaccine, or flu shot, is a vaccine designed to protect against influenza, also known as flu, a respiratory illness caused by influenza viruses. The increase in the prevalence of seasonal flu and recommendations for vaccination against the disease are the factors escalating the influenza vaccine market. The emphasis on the development of combination vaccines, mRNA vaccines, and others is providing growth opportunities in the influenza vaccine market. The surging trend towards the inclusion of advanced and effective vaccines in immunization programs is also responsible for escalating the market growth opportunities.

Report Coverage

This research report categorizes the market for the Germany influenza vaccine market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Germany influenza vaccine market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Germany influenza vaccine market.

Driving Factors

The increasing public health needs emphasizing influenza vaccination rates, especially among high-risk groups including the elderly age group, chronic diseased patients, pregnant women, and healthcare workers, is expected to drive the influenza vaccine market demand. The rapid advancement in vaccine technology, with the introduction of genetic engineering, significantly contributes to propelling the market growth. Further, the continued innovation and collaboration in vaccine R&D with reduced impacts of preventable diseases are expected to propel the market growth.

Restraining Factors

The stringent regulatory requirements and high development & production costs are restraining the influenza vaccine market. Further, the accessibility issues and need for cold storage may contribute to hamper the market growth.

Market Segmentation

The Germany influenza vaccine market share is classified into vaccine type, indication, and distribution channel.

• The inactivated segment dominated the market with the largest market share in 2023 and is expected to grow at the fastest CAGR during the projected timeframe.

Based on the vaccine type, the Germany influenza vaccine market is divided into inactivated and live attenuated. Among these, the inactivated segment dominated the market with the largest market share in 2023 and is expected to grow at the fastest CAGR during the projected timeframe. Inactivated vaccines consist of viruses, bacteria, and other pathogens that are grown in culture and then killed to destroy disease-producing capacity. The increasing demand for more convenient and effective vaccinations is contributing to driving the market demand in the inactivated segment.

• The quadrivalent segment dominated the market with the largest market share in 2023 and is expected to grow at the fastest CAGR during the projected timeframe.

Based on the indication, the Germany influenza vaccine market is divided into quadrivalent and trivalent. Among these, the quadrivalent segment dominated the market with the largest market share in 2023 and is expected to grow at the fastest CAGR during the projected timeframe. It is used for preventing influenza disease caused by influenza A and B viruses contained within the vaccine, which is approved for use in individuals 6 months of age and older. The increasing efficacy against viral infections, cost-effectiveness, and ease of access in clinics and hospitals are the factors that drive the market in the quadrivalent segment.

• The hospitals & pharmacies segment dominated the market with the largest revenue share in 2023 and is expected to grow at a significant CAGR during the projected timeframe.

Based on the distribution channel, the Germany influenza vaccine market is divided into hospitals & pharmacies, government & institutional supply, and other. Among these, the hospitals & pharmacies segment dominated the market with the largest revenue share in 2023 and is expected to grow at a significant CAGR during the projected timeframe. Hospital pharmacies primarily provide vaccines for elderly patients, while community pharmacies offer convenient and accessible vaccination options. The high prevalence of flu and influenza, which leads to higher hospital admissions, is anticipated to propel the market in the hospitals & pharmacies segment.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Germany influenza vaccine market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• GlaxoSmithKline (GSK)
• Sanofi
• AstraZeneca
• CSL Limited
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at Germany, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Germany Influenza Vaccine Market based on the below-mentioned segments:

Germany Influenza Vaccine Market, By Vaccine Type

• Inactivated
• Live Attenuated

Germany Influenza Vaccine Market, By Indication

• Quadrivalent
• Trivalent

Germany Influenza Vaccine Market, By Distribution Channel

• Hospitals & Pharmacies
• Government & Institutional Supply
• Other